Figure 3From: Efficacy and safety of a dual boosted protease inhibitor-based regimen, atazanavir and fosamprenavir/ritonavir, against HIV: experience in a pediatric population Mean values of lipids (TC, HDL, TG, LDL) in HIV-infected children and adolescents treated with double-boosted protease inhibitors during the study period. Back to article page